Introduction
It is well known that alfa-fetoprotein (AFP), an oncofetal glycoprotein with a molecular weight of approximately 70,000 Da, is a tumor marker that occurs mainly in hepatocellular carcinoma, yolk sac tumors, and the serum of patients with other malignant tumors. [1] [2] [3] The average concentration of AFP in healthy human serum is ,20 ng/mL, and serum AFP levels often increase in a number of disease states. 4 Therefore, detection of trace amounts of AFP is of great importance. Thus far, various immunosensors and immunoassays based on different measurement principles have been reported for determination of AFP, including enzyme-linked immunosorbent assay (ELISA), 5 electrochemiluninescence, 6, 7 chemiluminescence, 8, 9 surface plasmon resonance 10, 11 and quartz crystal microbalance. 12, 13 ELISA is the most widely used immunoassay method in the laboratory. However, concentrations of tumor-related proteins are very low in the early stages of cancer, and are beyond the detection limit of ELISA. Moreover, their lengthy analysis requires highly skilled personnel, specially equipped laboratories, and expensive reagents.
14 Thus, new methods that can rapidly and conveniently monitor tumor-related proteins are highly desirable. Electrochemical immunosensors, based on specificity of antigen-antibody interactions with electrochemical transducers, have attracted considerable interest because of their intrinsic advantages, such as low cost, high sensitivity, simple instrumentation, and excellent compatibility with miniaturization technologies. 15 Therefore, different electrochemical immunosensors, particularly amperometric immunosensors, have been developed and applied extensively for the determination of AFP. [16] [17] [18] In order to meet the increasing demand for early and ultrasensitive detection of tumor markers, three primary signal amplification strategies using nanomaterials have been developed. 19 The f irst method involves the use of metal and semiconductor nanoparticles directly as electroactive labels to amplify the electrochemical detection of proteins. 20, 21 The second method uses nanoparticles as carriers for loading a large amount of electroactive species to amplify the detection signal. 22, 23 The third method is the most extensively employed, and uses enzyme-functionalized nanoparticles as labels. Enhanced sensitivity was achieved by loading a large amount of enzyme towards an individual sandwich immunological reaction event. Recently, various types of nanomaterials have been used as carriers for loading enzymes and antibodies to enhance sensitivity, including gold nanoparticles, 24 irregularly shaped gold nanoparticles, 25 nanosilica particles, 26 carbon nanoparticles, 27 ,28 carbon nanotubes, 29 and graphene oxide. 30 For example, Chen et al have proposed a highly sensitive electrochemical immunosensor using irregular gold nanoparticles as carriers of horseradish peroxidase (HRP)-anti-AFP for signal amplification. 25 Similarly, Lin et al have reported use of graphene oxide, a novel tracer, to label HRP and the antibody, and developed an ultrasensitive immunoassay method for detection of phosphorylated p53 (S392). 30 Recently, hybrid nanomaterials consisting of two or more different nanoscale functionalities have attracted much attention due to their novel combined properties and multiple potential applications. 31 Immunomagnetic beads in particular are widely used in enrichment and separation of particular proteins in biology samples. [32] [33] [34] Among them, magnetic composite Fe 3 O 4 /Au nanoparticles have attracted particular attention, owing to the combined functions of Fe 3 O 4 and gold. Fe 3 O 4 nanoparticles have a typical superparamagnetic nature, and provide a convenient means for separation, isolation, and purification of biological samples via an external magnetic field when the functional reagents are attached onto the surface of the particles. 35, 36 Their unique structural, electronic, and optical properties make gold nanoparticles very attractive for several applications in biotechnology. [37] [38] [39] Further, gold nanoparticles can provide a natural environment for bimolecular immobilization and facilitate electron transfer of biosensors because of their large surface area, interesting electrochemical properties, and good biocompatibility. [40] [41] [42] Therefore, magnetic composite Fe 3 O 4 /Au nanoparticles have had more and more applications in areas such as immunoassays, protein immobilization, cell purification, and magnetically controlled transport of anticancer drugs. [43] [44] [45] [46] Our present work focuses on enzyme-enriched, magnetic functionalized nanoparticles in signal amplification and separation for ultrasensitive detection of AFP. Magnetic composite Fe 3 O 4 /Au nanoparticles were synthesized by assembling gold nanoparticles on SH-modified Fe 3 O 4 and using them as nanocarriers for immobilization of HRP and a secondary antibody (Ab 2 ). Greatly amplified sensitivity is achieved using bioconjugates featuring HRP and Ab 2 linked to Fe 3 O 4 /Au at a high HRP/Ab 2 ratio for replacement of singly labeled secondary antibodies. A modified glass carbon electrode with porous nanostructured gold film was used to attach the primary antibody (Ab 1 ). The analytical procedure consists of immunoreaction of the antigen (AFP) with Ab 1 , followed by binding of Fe 3 O 4 /Au-HRP-Ab 2 . Electrochemical detection was performed in the presence of H 2 O 2 and hydroquinone ( Figure 1) . The results demonstrated that an immunosensor based on this amplification strategy has a good dynamic range from 0.005 to 10 ng/mL and a low detection limit of 3 pg/mL for AFP. This simple, cost-effective, and sensitive immunosensor could find wide potential application in clinical analysis. 
Materials and methods reagents and materials
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Apparatus
Cyclic voltammetry measurements were performed using an electrochemical analyzer CHI 660 (Shanghai Chenhua Instrumental Corp, China) connected to a personal computer. A three-compartment electrochemical cell contained a platinum wire auxiliary electrode, a saturated calomel reference electrode, and a modified glass carbon electrode (GCE, 2 mm in diameter) as working electrode. The sizes of the nanoparticles were estimated from transmission electron microscopy (H-7650, Hitachi Instruments, Tokyo, Japan). The surface topographic features and composition of variously modified electrodes were characterized using scanning electron microscopy coupled with energy dispersive spectroscopy (SEM-EDS, S3400N Hitachi). The x-ray powder diffraction images were obtained using a Bruker D8 Advance diffractometer (Bruker, Karlsruhe, Germany). Ultraviolet-visible spectra were recorded using a TU-1901 spectrophotometer (Purkinje General Instrument Co, Beijing, China). The x-ray photoelectron spectra were taken using an AXIS UltraDLD spectrometer (Shimadzu Co, Tokyo, Japan). Vibrating sample magnetometry (Lake Shore 7410) was used to perform magnetic measurements on the dried samples to evaluate the magnetic properties of the nanoparticles. Figure 1A shows the procedure used to prepare the Fe 3 O 4 /Au. First, gold nanoparticles was prepared using the Frens method. 47 In brief, 0.01 wt% HAuCl 4 (100 mL) was boiled with vigorous stirring in a flask. Trisodium citrate 1 wt% solution (2.5 mL) was added quickly to the boiling solution, resulting in a color change from pale yellow to dark red, indicating formation of gold nanoparticles. The solution was maintained for 10 minutes at boiling temperature. Fe 3 O 4 /Au nanoparticles were obtained by self-assembling gold nanoparticles onto the surface of SH-modified Fe 3 O 4 according to the literature with modification. 48 Fe 3 O 4 nanoparticles are commercially available. Experimentally, Fe 3 O 4 0.2 g was dispersed in 50% ethanol 90 mL by ultrasound, and then 3-MPTES 300 µL and ammonium hydroxide 500 µL were added dropwise. The mixture was stirred at 60°C for 6 hours under a nitrogen atmosphere. Uncoated Fe 3 O 4 was deleted by means of washing with 0.1 M HCl (six times, for four hours each). The deposit was separated by a magnetic stirrer, which was rinsed three times with double deionized water and then ethanol to give SH-modified Fe 3 O 4 . Following that, the gold nanoparticles were added to the SH-modified Fe 3 O 4 , and shaken slightly for 4 hours at room temperature to make the gold assemble on the surface of the formed nanoparticles. After magnetic separation, the Fe 3 O 4 /Au obtained were rinsed with double deionized water and suspended in 10 mL water. 
Preparation of Fe 3 O 4 /Au nanoparticles
Dovepress
using Na 2 CO 3 . Thereafter, 200 µL of HRP at 1 mg/mL and 200 µL of Ab 2 at 10 µg/mL were added to the dispersion, and the mixture was stirred overnight at 4°C. After magnetic separation and washing three times, the resulting mixture was redispersed in 1.0 mL of pH 7.4 phosphate-buffered solution containing 1% bovine serum albumin and stored at 4°C.
Fabrication of the immunosensor
The procedure followed to prepare the proposed immunosensor is schematized in Figure 1C . The GCE was polished with 0.3 µm and 0.05 µm alumina, followed by successive sonication in distilled water and ethanol for 5 minutes and dried in air. A porous nanostructure gold film was then deposited at a voltage of −0.5 V for 50 seconds on the clean GCE that was immersed in 5 mL 0.08 M HAuCl 4 solution containing 0.004 M lead acetate. After thorough washing with water, the electrode was immediately followed by incubation with 20 µL 0.5 mg/mL Ab 1 for one hour. After washing with 0.05% Tween-20 and phosphate-buffered solution, Ab 1 /Au/GCE was incubated in 3% bovine serum albumin and phosphate-buffered solution at 37°C for one hour to block excess active groups and nonspecific binding sites on the surface. The electrode was then washed with 0.05% Tween-20 and phosphate-buffered solution before use.
Immunoassay procedure for detection of AFP Figure 2C ). Upon deposition of gold onto the Fe 3 O 4 nanoparticles, the diameter of the particles increased by about 20 nm, demonstrating that the thickness of the gold was about 10 nm. Figure 3A compares the x-ray powder diffraction pattern for the Fe 3 O 4 nanoparticles and Fe 3 O 4 /Au nanoparticles. In Figure 3A 
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Magnetic nanoparticle amplification for AFP immunoassay photoelectron spectra as shown in Figure 3B . Figure 3B shows gold peaks including Au 4s, Au 4p, Au 4d, and Au 4f appearing on the surface of the Fe 3 O 4 nanoparticles. The Au 4f appearing at 80-90 eV can be assigned to the Au 0 . The Fe 3 O 4 showed Fe 2p at 700-720 eV. The x-ray photoelectron spectra result was in agreement with a report by Cui et al indicating that gold had been successfully assembled on the surface of the magnetic Fe 3 O 4 nanoparticles. 48 The magnetic properties of the nanoparticles are illustrated in Figure 4 . It can be seen that a small coercivity or remanence existed around room temperature, indicating the seM-eDs characterization of gold nanoparticles modified electrode with direct electroposition SEM-EDS were used to investigate the successful fabrication of the immunosensor. Figure 6A shows the energy dispersive spectroscopy analysis of Au/GCE showing Au-M (2.0 keV), Au-Lα (9.7 keV), and Au-Lβ (11.4 keV), which indicates successful electrodeposition of gold on the GCE. Furthermore, scanning electron microscopy was used to investigate the Au/GCE before and after modification with Ab 1 . As shown in Figure 6B , many small porous gold nanoparticles were obtained on the Au/GCE. Obviously, the 
electrochemical characterization of the immunosensor
As shown in Figure 7 , the cyclic voltammograms of Ab 1 /Au/ GCE did not show any detectable signal in pH 6.5 phosphatebuffered solution (curve a). Upon adding 2 mM hydroquinone and 5 mM H 2 O 2 to the phosphate-buffered solution, Ab 1 /Au/ GCE exhibited a pair of stable and well defined redox peaks at −145 mV and 345 mV (curve b), corresponding to the electrochemical redox response of hydroquinone on the electrode surface. When incubating the immunosensor with 5 ng/ mL AFP antigen, no obvious change in signal was observed.
However, after incubation with Fe 3 O 4 /Au-HRP-Ab 2 , the resulting sandwich immunocomplex displayed an obvious increase in electrocatalytic reduction current (curve c) because of the introduction of HRP onto the electrode surface by the immunoreaction.
comparison of detection antibodies with various labels
To investigate further the effect of the synthesized 
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Magnetic nanoparticle amplification for AFP immunoassay three types of detection antibodies were used, ie, HRPanti-Ab 2 , Au-HRP-Ab 2 , and Fe 3 O 4 /Au-HRP-Ab 2 ( Figure 8 ).
As shown in Figure 8A -C, upon addition of H 2 O 2 to the substrate solution, an obvious catalytic characteristic appeared, with a distinct increase in the reduction current and a decrease in the oxidation current. The catalytic current is mainly due to the labeled HRP toward the reduction of H 2 O 2 with the help of hydroquinone as an electron mediator. As shown in Figure 8 , we found that the electrochemical immunosensor exhibited a larger current shift using Au-HRP-Ab 2 ( Figure 8B ) as the detection antibody than when using HRP-anti-Ab 2 ( Figure 8A ). The reason for this might be that the gold nanoparticles with a high surface-to-volume ratio and good biocompatibility can load more HRP and Ab 2 . Moreover, gold nanoparticles have good conductivity, which can enhance enzyme activity. 49 More significantly, the electrochemical responses could be improved by using 
Optimization of immunoassay conditions
Because of the coimmobilization of enzymes and antibodies on the Fe 3 O 4 /Au nanocarrier, the ratio of HRP and Ab 2 is the most important factor in the response signal. As shown in Figure 9A , one can see that the electrocatalytic current increases with an increasing ratio of HRP/Ab 2 , and the maximum response is achieved at a ratio of 100:1. An increase in the HRP/Ab 2 ratio could increase the total amount of HRP loaded per Fe 3 O 4 /Au nanocarrier, which would be expected to increase the response amplification for this sandwich immunoassay. However, reducing the amount of Ab 2 in the immunoassay may decrease the efficiency of the immune reaction to the AFP antigen captured at the electrode surface, which may result in a decreased response. Therefore, an HRP/Ab 2 ratio of 100:1 was selected as the optimal condition in which to prepare the Fe 3 O 4 /Au-HRP-Ab 2 conjugate. To determine the amount of active HRP in the Fe 3 O 4 /Au-HRPAb 2 conjugate dispersion, the mixture was reacted with the TMB substrate for HRP. The reaction product was read at 650 nm. These results were compared with a standard curve constructed using pure HRP as part of an enzyme activity experiment. The concentration of active HRP in the Fe 3 O 4 / Au-HRP-Ab 2 conjugate dispersion was determined to be 7.14 µg/mL.
The pH of the detection solution is an important parameter because the acidity of the solution is greatly affected by the activity of immobilized proteins. The effect of pH 
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of the solution on the amperometric response for AFP is shown in Figure 9B . The current response was increased by increments in pH from 4.0 to 6.5 and then decreased when pH exceeded 6.5. Therefore, a 0.1 M solution of pH 6.5 was selected as the optimum solution for AFP detection.
The temperature and time taken for the antigen-antibody interaction to occur greatly influenced the sensitivity of the sandwich-type immunoassay developed. Considering the practical applications of the proposed system in clinical immunoassays, all experiments were carried out at room temperature (25°C ± 1.0°C). Under this condition, the effect of various incubation times (10-45 minutes) on the immunosensor current was investigated at 1 mg/mL of AFP. As shown in Figure 9C , the reduction current increased with increasing incubation time and tended to level off after 30 minutes, indicating optimal formation of the sandwichtype immunocomplexes. A longer incubation time could not improve the response. Therefore, 30 minutes of incubation time was used for the detection of AFP in this study.
Analytical performance
The cyclic voltammograms of the immunosensor was investigated by assaying various AFP standards using These results suggest that Fe 3 O 4 /Au could greatly improve the sensitivity and work range of the immunosensor. Although the threshold of human serum AFP is 10 ng/mL, actual serum samples should be diluted during the clinical diagnostic process, so the concentrations detected are usually ,10 ng/mL. Small volume samples are preferable. Thus, the sensitivity of this immunoassay was adequate for practical application.
Regeneration of immunosensors is of great interest to immunoanalysts. Traditional regeneration of the immunosensor usually requires a different regeneration solution, such as an Immunosensor specificity, reproducibility, and stability
Specificity is an important feature of the immunosensor. To investigate this, the immunosensor was incubated with 1 ng/mL AFP containing a different interference substance, such as carcinoma antigen 125, carcinoembryonic antigen, human IgG, prostate-specific antigen, and bovine serum albumin. No remarkable change of currents was observed in comparison with the results obtained in the presence of AFP only, indicating good selectivity of the proposed AFP immunosensor. The reproducibility of the proposed immunosensor was evaluated by intra-assay and interassay coefficients of variation. The intra-assay precision of the analytical method was evaluated by analyzing one immunosensor for six replicate determinations. Coefficients of variation for the intra-assay were 3.6% and 4.7% at 0.1 ng/mL and 1.0 ng/mL AFP, respectively. Similarly, the interassay coefficients of variation for six immunosensor determinations were 3.9% and 5.5% at 0.1 ng/mL and 1.0 ng/mL AFP, respectively. These results demonstrate the acceptable reproducibility and precision of the proposed immunosensor.
We also examined the stability of the developed immunosensor. When not in use, the immunosensor could be stored in pH 7.0 phosphate-buffered solution at 4°C for at least 3 weeks without any obvious signal change. Moreover, the immunosensor retained 89.4% of its initial response after a storage period of 4 weeks. The slow decrease in current response may be attributed to gradual deactivation of biomolecules immobilized on the nanoparticle surface.
Application of the immunosensor in human serum
The electrochemical immunosensor was further validated by assaying six serum specimens gifted from the Nanfang Medical Hospital, China. The serum was prepared by collecting whole blood, leaving it undisturbed for 15-30 minutes at room temperature to clot, and then removing the clot by centrifugation at 1000-2000 rpm for 10 minutes in a refrigerated centrifuge, and collecting the supernatant serum. Table 1 describes the correlation between the partial results obtained by the proposed immunosensor and the ELISA method, indicating no significant difference between the two methods, ie, the proposed immunosensor could be used for satisfactory clinical determination of AFP levels in human serum.
Conclusion
We have successfully designed a multienzyme labeling Fe 3 O 4 /Au strategy as part of a signal amplification procedure and demonstrated its use in the ultrasensitive, selective, and accurate quantification of AFP by electrochemical immunoassay. Highlights of the developed immunoassay are: Fe 3 O 4 /Au as the enzyme-loading carrier can load many enzyme molecules on each Fe 3 O 4 /Au nanoparticle, thus enhancing the sensitivity of the immunosensor; using Fe 3 O 4 /Au as signal enhancers favors rapid separation and purification of the signal antibody on an external magnetic field; after each detection, the immunosensor can be easily regenerated by applying an external magnetic field. The proposed immunosensor has high sensitivity, good reproducibility, stability, and accuracy. We anticipate that this method can be extended for determination of other proteins and have promising potential in clinical applications. 
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